Pfizer Boasts of ‘Blockbuster’ Profits from Treating Turbo Cancer Surge
Pfizer CEO Albert Bourla has gloated that his pharmaceutical company is expecting to reap “blockbuster” profits from treating the global surge in turbo cancers among the Covid-vaccinated.